Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
157.34B
Market cap157.34B
Price-Earnings ratio
36.63
Price-Earnings ratio36.63
Dividend yield
6.22%
Dividend yield6.22%
Average volume
33.87M
Average volume33.87M
High today
$27.70
High today$27.70
Low today
$27.34
Low today$27.34
Open price
$27.64
Open price$27.64
Volume
75.59M
Volume75.59M
52 Week high
$29.21
52 Week high$29.21
52 Week low
$23.58
52 Week low$23.58

Stock Snapshot

The current Pfizer(PFE) stock price is $27.62, with a market capitalization of 157.34B. The stock trades at a price-to-earnings (P/E) ratio of 36.63 and offers a dividend yield of 6.22%.

On 2026-09-19, Pfizer(PFE) stock traded between a low of $27.34 and a high of $27.70. Shares are currently priced at $27.62, which is +1.0% above the low and -0.3% below the high.

The Pfizer(PFE)'s current trading volume is 75.59M, compared to an average daily volume of 33.87M.

In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.58.

In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.58.

PFE News

Nasdaq 1h
Is Pfizer an Excellent Dividend Stock to Buy?

Pfizer (NYSE: PFE) has experienced unprecedented circumstances in the previous decade. Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think the...

Is Pfizer an Excellent Dividend Stock to Buy?
24/7 Wall St. 1d
Pfizer's Dividend Yield Is Enormous. But Is the Payout Still Growing?

Investing Pfizer’s Dividend Yield Is Enormous. But Is the Payout Still Growing? Pfizer has raised its dividend every year for over a decade, then something chan...

Pfizer's Dividend Yield Is Enormous. But Is the Payout Still Growing?
Simply Wall St 1d
Pfizer, Why Is The Market Watching So Closely? - simplywall.st

...

Pfizer, Why Is The Market Watching So Closely? - simplywall.st

Analyst ratings

61%

of 28 ratings
Buy
32.1%
Hold
60.7%
Sell
7.1%

More PFE News

TipRanks 2d
Health Canada authorizes Pfizer, BioNTech’s Omicron XFG-adapted Covid-19 vaccine

Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has authorized the XFG variant-adapted COMIRNATY for active immunization of individuals age...

Nasdaq 2d
Pfizer's Dividend Faces Big Questions. Here Are 3 Reasons It Should Survive.

Key Points Pfizer's management remains firmly committed to maintaining the dividend. The company's growth portfolio is performing well. Pfizer's cash stockpi...

Pfizer's Dividend Faces Big Questions. Here Are 3 Reasons It Should Survive.
Nasdaq 5d
Blackrock Moves Up In Market Cap Rank, Passing Pfizer

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Blackrock Inc (Symbol: BLK) has taken over the #77 spot...

Blackrock Moves Up In Market Cap Rank, Passing Pfizer
24/7 Wall St. 5d
Pfizer's 6% Yield Masks a Fragile Dividend Story

Investing Pfizer’s 6% Yield Masks a Fragile Dividend Story Pfizer's payout looks like a safe harbor in a rough market, but the patent clock is ticking and the b...

Pfizer's 6% Yield Masks a Fragile Dividend Story
TipRanks 6d
Pfizer aims at air-traffic controllers for Covid-19 vaccine money, WSJ says

In an attempt to get paid for millions of unwanted Covid-19 vaccines, Pfizer (PFE) is taking aim at air-traffic controllers, Benjamin Katz of The Wall Street Jo...

The Wall Street Journal 6d
Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines

Polish and Romanian regulators say Pfizer’s move could jeopardize air safety. Mateusz Wlodarczyk / NurPhoto / Getty Images Pfizer PFE 0.25 %increase; up pointi...

Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.